Ascendis Pharma Director Lars Holtug Sells ~$62.3K in Ordinary Shares
Ascendis Pharma A/S
Subscribe to track ASND
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š Insider Sale Alert: ASND ā¢ Insider: Lars Holtug (Director) ā¢ Transaction: Sold 236 Ordinary Shares @ $264.13 ā¢ Total Value: $62,334.59 ā¢ Remaining Holdings: 4,000 shares ā¢ Filing Date: September 3, 2026
Comprehensive Analysis
Insider Transaction Summary: Ascendis Pharma A/S (NASDAQ: ASND)
On September 2, 2026, Lars Holtug, a Director at Ascendis Pharma A/S, executed an open-market sale of 236 ordinary shares at a price of $264.1296 per share, totaling approximately $62,334.59.
Key Details:
- Insider: Lars Holtug (Director)
- Transaction Type: Open Market Sale (Code
S) - Shares Sold: 236 shares
- Execution Price: $264.1296
- Post-Transaction Beneficial Ownership: 4,000 ordinary shares (Direct)
- Rule 10b5-1 Indicator: No Rule 10b5-1 trading plan check indicated (
aff10b5Oneis false)
Market Impact & Context:
Given the low share count (236 shares) and modest total value (~$62.3K) relative to Holtug's remaining position of 4,000 shares and the company's overall market capitalization, this transaction carries Low trading significance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.